Literature DB >> 2500072

Danazol stimulates the release of follicle-stimulating hormone and inhibits the release of prolactin in vitro studies on rat pituitary cell cultures.

K Kugu1, K Kohda, Y Taketani, M Mizuno.   

Abstract

The actions of danazol on the release of gonadotropins and prolactin (PRL) were investigated by using a culture of rat anterior pituitary gland cells. The addition of danazol in the range between 10(-9) M and 10(-5) M elevated the levels of follicle-stimulating hormone (FSH) in a dose-dependent manner. Danazol at 10(-5) M caused a 70% increase in FSH levels over the control. The intracellular contents of FSH was also increased by danazol, suggesting its stimulatory effect on both the synthesis and release of FSH. Danazol had no effect on the release of luteinizing hormone (LH). Danazol diminished the sensitivity of gonadotrophs to luteinizing hormone-releasing hormone (LHRH) in that the LHRH-induced release of both FSH and LH was suppressed. The amount of PRL released into medium was decreased by danazol in a dose-dependent way.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500072     DOI: 10.1007/bf00931293

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  16 in total

1.  STEROIDAL HETEROCYCLES. VII. ANDROSTANO(2,3-D)ISOXAZOLES AND RELATED COMPOUNDS.

Authors:  A J MANSON; F W STONNER; H C NEUMANN; R G CHRISTIANSEN; R L CLARKE; J H ACKERMAN; D F PAGE; J W DEAN; D K PHILLIPS; G O POTTS; A ARNOLD; A L BEYLER; R O CLINTON
Journal:  J Med Chem       Date:  1963-01       Impact factor: 7.446

2.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

3.  Danazol inhibits steroidogenesis by the human ovary in vivo.

Authors:  K A Steingold; J K Lu; H L Judd; D R Meldrum
Journal:  Fertil Steril       Date:  1986-05       Impact factor: 7.329

Review 4.  Endocrine properties and clinical application of danazol.

Authors:  W P Dmowski
Journal:  Fertil Steril       Date:  1979-03       Impact factor: 7.329

5.  Effects of danazol on pulsatile gonadotropin patterns and on serum estradiol levels in normally cycling women.

Authors:  W P Dmowski; S Headley; E Radwanska
Journal:  Fertil Steril       Date:  1983-01       Impact factor: 7.329

6.  The effect of danazol on the pituitary function, thyroid function, and mastodynia.

Authors:  F Peters; G Reck; G Zimmermann; M Breckwoldt
Journal:  Arch Gynecol       Date:  1980

7.  A receptor site for prolactin in lactating mouse mammary tissues.

Authors:  S Sakai; K Kohmoto; T Johke
Journal:  Endocrinol Jpn       Date:  1975-10

8.  Inhibition of gonadotropin-releasing hormone receptors in rat anterior pituitary monolayer cell cultures by danazol.

Authors:  M Menon; H Peegel; V Katta
Journal:  Am J Obstet Gynecol       Date:  1986-02       Impact factor: 8.661

9.  Influence of Danazol on gonadotropin secretion and synthesis by rat pituitary cells in cultures. Comparison with gonadal steroids.

Authors:  A Demoulin; R Lambotte; P Franchimont
Journal:  Acta Eur Fertil       Date:  1984 Mar-Apr

10.  Danazol: endocrine and endometrial effects.

Authors:  W S Floyd
Journal:  Int J Fertil       Date:  1980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.